DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY
A diagnostic prospective single-site study, with no anticipated risks or constraints.
Primary objective- To validate the value of a set of breath VOC biomarkers that enable us to
distinguish between Coronavirus (SARS-CoV-2) carriers and SARS-CoV-2-negative in comparison
to the gold-standard testing methodology.
Diagnostic Test: Breath Biopsy Analysis
Analysis of a single breath Biopsy
Inclusion Criteria:
- Age 6 to 75 years at the time of consent
- Capable of understanding written and/or spoken language
- Able to provide informed consent
- Was not treated with Anti-viral drugs
Exclusion Criteria:
- Age under 6 years old
- Under guardianship or deprived of liberty
- Pregnant or lactating woman
Shamir Medical Center
Be'er Ya'aqov, Israel
Natalie Dror, PhD, Study Director
Scentech Medical Technologies Ltd